Table 2.
Sample number | Ferrofluid/blood (μl/mL) | Flow rate (mL/hr) | Screen volume (mL) | Numbers of CTCs | Gender | Cancer type | Numbers of CTCs/7.5mL (Microchip) | Numbers of CTCs/7.5mL (CellSearch) |
---|---|---|---|---|---|---|---|---|
1 | 7.5 | 2.5 | 5 | 30 | F | Breast cancer | 20 | 16 |
2 | 7.5 | 2.5 | 10 | 50 | F | Breast cancer | 33 | 10 |
3 | 7.5 | 2.5 | 5 | 1 | M | Prostate cancer | 0.6 | 3 |
4 | 7.5 | 2.5 | 5 | 1 | F | Lung Cancer | 0.6 | N/A |
5 | 7.5 | 2.5 | 5 | 1 | F | Lung Cancer | 0.6 | N/A |
6 | 7.5 | 2.5 | 7.5 | 5 | F | Breast cancer | 3 | N/A |
7 | 7.5 | 2.5 | 5 | 19 | F | Breast cancer | 13 | N/A |
8 | 7.5 | 2.5 | 5 | 28 | F | Lung Cancer | 19 | N/A |
9 | 7.5 | 2.5 | 5 | >1000 | F | Breast cancer | >666 | N/A |
10 | 7.5 | 2.5 | 7.5 | 1 | F | Breast cancer | 0.6 | N/A |
11 | 7.5 | 2.5 | 7.5 | 1 | F | Breast cancer | 0.6 | N/A |